Local Biotech Company Agilvax’s Cancer Immunotherapy Technology Shows Promising Results
Local start-up company Agilvax, Inc., headquartered in Albuquerque, is commercializing a virus-like particle (VLP) technology platform developed by UNM researchers Dr. David Peabody and Dr. Bryce Chackerian and cancer immunotherapies […]